Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $90.21 | $20.67 | 336.49% | 196.11x | 172.29x | 12.25x | 15.18x | 1.65x | $119.79M | 1.27% | $637.99M | 6.11 | $9.59B | -1,396.02 | ||
| LQDA | LIQUIDIA CORP | $78.93 | $17.59 | 348.72% | 328.88x | 23.11x | 24.12x | 64.65x | 1.62x | $41.15M | 0.59% | $108.58M | 1.23 | $6.98B | 130.25 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.28 | $2.91 | 184.22% | 118.29x | 77.31x | 4.49x | 109.87x | 1.09x | $47.52M | 3.37% | $13.01M | 0.08 | $1.58B | 29.50 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $312.78 | $93.15 | 235.77% | 71.74x | 41.47x | 9.70x | 38.83x | 1.49x | $641.34M | 1.54% | $1.08B | 8.09 | $43.02B | 46.53 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $64.53 | $17.25 | 274.00% | 65.85x | 50.54x | 6.55x | 8.20x | 1.78x | $164.23M | 3.33% | $605.69M | 7.92 | $4.78B | 42.91 | ||
| KRYS | KRYSTAL BIOTECH INC | $375.07 | $95.01 | 294.76% | 48.40x | 47.17x | 26.32x | 8.66x | 2.31x | $237.38M | 2.16% | $1.28B | 43.59 | $10.56B | 49.38 | ||
| HALO | HALOZYME THERAPEUTICS INC | $79.45 | $71.06 | 11.80% | 26.84x | 9.58x | 6.22x | 42.91x | 0.48x | $667.65M | 7.11% | $219.64M | 1.86 | $11.26B | 18.04 | ||
| VCEL | VERICEL CORP | $46.98 | $9.10 | 416.22% | 109.26x | 97.45x | 8.17x | 6.73x | 2.30x | $47.49M | 1.99% | $356.23M | 7.02 | $2.38B | 58.99 | ||
| ADMA | ADMA BIOLOGICS INC | $8.95 | $9.79 | -8.61% | 12.97x | 9.79x | 4.14x | 5.31x | 0.49x | $107.90M | 5.11% | $390.33M | 1.65 | $2.13B | 9.63 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.99 | $41.62 | 41.74% | 42.14x | 15.56x | 3.50x | 1.84x | 0.58x | $767.06M | 6.76% | $6.21B | 32.27 | $9.76B | 20.23 | ||
| RPRX | ROYALTY PHARMA PLC | $57.77 | $39.73 | 45.42% | 30.25x | 10.83x | 10.34x | 3.35x | 0.65x | $2.34B | 9.28% | $9.94B | 22.75 | $41.64B | 35.79 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.98 | $15.90 | -12.10% | 6.82x | 29.16x | 6.68x | 4.02x | 0.91x | $56.42M | 6.91% | $205.80M | 3.52 | $731.98M | 5.06 | ||
| ASND | ASCENDIS PHARMA A | $274.50 | $80.38 | 241.50% | 29.09x | 18.40x | 16.74x | 29.70x | 2.98x | $52.94M | 0.31% | $574.09M | 9.24 | $17.43B | 186.91 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.47 | $49.21 | 394.77% | 518.02x | 9.46x | 3.40x | 3.37x | 1.74x | $1.30B | 8.61% | $4.53B | 73.22 | $18.83B | 27.90 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $319.55 | $94.02 | 239.89% | 40.45x | 35.21x | 23.15x | 6.42x | 2.04x | $122.22M | 1.92% | $997.32M | 50.16 | $6.74B | 29.89 | ||
| TGTX | TG THERAPEUTICS INC | $53.31 | $16.97 | 214.18% | 16.56x | 38.11x | 10.99x | 13.99x | 262.35x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.47B | 56.46 | ||
| TECH | BIO-TECHNE CORP | $70.83 | $16.72 | 323.66% | 99.76x | 33.90x | 9.15x | 5.32x | 1.82x | $269.60M | 2.44% | $2.09B | 13.34 | $11.17B | 43.64 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.26 | $35.61 | 4.64% | 14.73x | 10.13x | 2.40x | 2.37x | 0.56x | $341.79M | 15.86% | $910.35M | 15.75 | $1.73B | 7.29 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.20 | $5.71 | -61.49% | 8.15x | 3.22x | 2.06x | 2.41x | 0.17x | $7.24M | 5.73% | $52.93M | 0.92 | $73.73M | 4.76 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $528.04 | $167.27 | 215.68% | 31.04x | 27.01x | 10.98x | 6.92x | 2.27x | $3.71B | 2.77% | $19.36B | 76.20 | $130.51B | 24.20 | ||
| UTHR | UNITED THERAPEUTICS CORP | $555.91 | $242.28 | 129.45% | 18.99x | 19.54x | 7.63x | 4.00x | 2.10x | $1.02B | 4.21% | $5.90B | 135.66 | $22.32B | 13.02 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.43 | $2.45 | 40.01% | 14.29x | 14.50x | 2.10x | 3.32x | 0.96x | $4.11M | 1.49% | $82.33M | 1.03 | $209.21M | 9.85 | ||
| EXEL | EXELIXIS INC | $55.85 | $30.72 | 81.78% | 17.90x | 16.95x | 6.07x | 7.25x | 1.30x | $917.69M | 6.36% | $1.94B | 7.49 | $13.98B | 13.24 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.45 | $12.20 | 157.80% | 17.38x | 16.04x | 6.44x | 3.80x | 3.90x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.24 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $654.27 | $434.28 | 50.66% | 15.37x | 13.91x | 4.56x | 2.18x | 1.04x | $4.11B | 6.04% | $31.42B | 302.15 | $68.34B | 11.90 | ||
| INCY | INCYTE CORP | $116.86 | $66.60 | 75.47% | 16.03x | 14.92x | 4.35x | 4.15x | 1.38x | $1.45B | 6.23% | $5.62B | 28.21 | $19.92B | 10.65 | ||
| VCYT | VERACYTE INC | $57.08 | $7.57 | 654.00% | 51.42x | 51.18x | 8.38x | 3.39x | 10.95x | $155.34M | 3.42% | $1.34B | 16.90 | $4.33B | 37.63 | ||
| MDXG | MIMEDX GROUP INC | $3.95 | $1.25 | 216.00% | 18.81x | -46.91x | 1.51x | 2.42x | 8.94x | $69.36M | 11.82% | $242.94M | 1.64 | $446.16M | 8.19 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.28 | $3.59 | 436.61% | 32.13x | 5.26x | 0.93x | 1.35x | 14.54x | $109.24M | 5.39% | $1.51B | 14.34 | $2.61B | 31.52 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.